Johnson Chemical Pharmaceutical Works Co 4747.TWO · TWD
Health Care · Taipei Exchange · 🇹🇼 Taiwan
19.45
-9.95%
Close of 9 Nov 2026, in TWD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Johnson Chemical Pharmaceutical Works Co
Its shares trade on Taipei Exchange under the ticker 4747.TWO. It has been listed since 8 January 2010. In the fiscal year to 31 December 2025, it reported revenue of TWD 569.8m and net income of TWD 53.5m. At that date it held total assets of TWD 2.09bn and shareholders' equity of TWD 1.71bn.
Johnson Chemical Pharmaceutical Works Co., Ltd. engages in the manufacture and sale of drug and pharmaceuticals products. The company is headquartered in Taipei, New Taipei. The company went IPO on 2010-01-08. The firm mainly provides solid dosage forms, including soft and hard capsules, sugar coated tablets, film-coated tablets, suppositories, powder, granules, tablets and others. The Company’s products include central nervous system drugs, hormones and hormone function medicines, respiratory medicines, gastrointestinal drugs, vitamins and others. The firm mainly distributes its products in Taiwan market and the rest of Asia.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Listed since
- 8 Jan 2010
- Employees
- 111
- Website
- jcpjohnson.com.tw ↗
Leadership
Pay as last reported
- Boxiong HuangChairman of the Board, General Manager, since 1992
- Yicong QiuDeputy General Manager-Business
- Yixiu ChenHead of Finance and Accounting, Corporate Governance Officer
- Fengzi GuoDirector
- Mingyu GuoDirector
- Boxun HuangDirector
- Jingquan LiaoDirector
- Rongfu YangDirector
- Mr. Zongcheng LaiIndependent Director
- Jianfa LanIndependent Director
- Mr. Zhiheng LiIndependent Director
- Junwei LinIR Contact Officer
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Johnson Chemical Pharmaceutical Works Co Ltd manufactures solid dosage forms including capsules and tablets in Taiwan.
- The company focuses on central nervous system drugs and respiratory medicines for the Asian market.
- With 111 employees, the firm efficiently operates within the Health Care sector.
Weaknesses
- The company's primary market is limited to Taiwan and Asia, restricting global expansion.
- The firm relies on traditional pharmaceutical products without mentioning innovative drug development.
- No mention of international distribution channels beyond Asia in the business description.
Opportunities
- Expanding into new markets like North America could increase the company's global presence.
- Growing demand for respiratory medicines in Asia presents a significant market opportunity.
- Increasing focus on vitamins and gastrointestinal drugs aligns with health trends in Asia.
Threats
- Competition from international pharmaceutical companies in the Asian market.
- Regulatory changes in Taiwan could impact the company's operations.
- Economic downturns in Asia might reduce demand for pharmaceutical products.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.